Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 11:49 ET | Source: Research and Markets

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a...
April 02, 2026 11:30 ET | Source: SNS Insider pvt ltd

Test Strip Market Set to Hit USD 22.91 Billion by 2035, Driven by Rising Diabetes Burden – SNS Insider

Austin, United States, April 02, 2026 (GLOBE NEWSWIRE) -- Test Strip Market Size & Growth Analysis: According to SNS Insider, The Test Strip Market size is valued at USD 14.79 Billion in 2025...
April 02, 2026 10:49 ET | Source: Faruqi & Faruqi LLP

QURE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UniQure To Contact Him Directly To Discuss Their Options If you purchased or...
April 02, 2026 10:47 ET | Source: Research and Markets

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Metastatic Lung Adenocarcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The metastatic lung...
April 02, 2026 10:45 ET | Source: Faruqi & Faruqi LLP

AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aquestive To Contact Him Directly To Discuss Their Options If you purchased or...
April 02, 2026 10:41 ET | Source: Research and Markets

Hemophagocytic Lymphohistiocytosis Market Outlook Report 2026-2030 - Increasing Autoimmune Disease Prevalence Fuels HLH Market Expansion at 5.8% CAGR

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Hemophagocytic Lymphohistiocytosis Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insights...
April 02, 2026 10:38 ET | Source: SkyMedia, LLC

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

NEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a...
April 02, 2026 10:36 ET | Source: SkyMedia, LLC

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

NEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a...
April 02, 2026 10:30 ET | Source: Faruqi & Faruqi LLP

RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In REGENXBIO To Contact Him Directly To Discuss Their Options If you purchased or...
April 02, 2026 10:23 ET | Source: Schall Law

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm